CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia

Published:2013-08-15 Issue:9 Volume:4 Page:1438-1448
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Astori Audrey¹²³,Fredly Hanne⁴⁵,Aloysius Thomas Aquinas⁶,Bullinger Lars⁷,Mas Véronique Mansat-De⁸⁹,de la Grange Pierre¹⁰,Delhommeau François¹¹¹²,Hagen Karen Marie⁴⁵,Récher Christian⁸⁹,Dusanter-Fourt Isabelle¹²³,Knappskog Stian⁶,Lillehaug Johan Richard⁶,Pendino Frédéric¹²³⁶,Bruserud Øystein⁴⁵

Affiliation:

1. Inserm, U1016, Institut Cochin, F-75014, Paris, France

2. CNRS, UMR8104, F-75014, Paris, France

3. Université Paris Descartes, Sorbonne Paris Cité, Paris, France

4. Section for Hematology, Institute of Medicine, University of Bergen, Norway

5. Department of Medicine, Haukeland University Hospital; Bergen, Norway

6. Department of Molecular Biology, University of Bergen, Bergen, Norway

7. Department of Internal Medicine III, University of Ulm, Ulm, Germany

8. Inserm, Unité Mixte de Recherche 1037-Cancer Research Center of Toulouse, CNRS 5294, Université de Toulouse, Centre Hospitalier Universitaire Purpan, F-31059, Toulouse, France

9. Service d'Hématologie, Centre Hospitalier Universitaire Purpan, Hôpital Purpan, F-31059, Toulouse, France

10. GenoSplice, Hôpital Saint-Louis, F-75010, Paris, France

11. UPMC, Pierre and Marie Curie University, GRC n°07, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC, F-75012, Paris, France

12. AP-HP, Hôpital Saint-Antoine, Service d'Hématologie et Immunologie Biologiques, F-75012, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia;Cancers;2023-07-21

2. A CpG island promoter drives the CXXC5 gene expression;Scientific Reports;2021-08-02

3. The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cell expansion;Haematologica;2020-11-26

4. CXXC5 Attenuates Pulmonary Fibrosis in a Bleomycin-Induced Mouse Model and MLFs by Suppression of the CD40/CD40L Pathway;BioMed Research International;2020-04-04

5. Frontline Science: Cxxc5 expression alters cell cycle and myeloid differentiation of mouse hematopoietic stem and progenitor cells;Journal of Leukocyte Biology;2020-02-21